Drug: panitumumab Injury: Palmar-plantar erythrodysaesthesia syndrome Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
88186503 | PANITUMUMAB | Palmar-plantar erythrodysaesthesia syndrome | ROCHE | 0.00 | 0 | 20160913 | DK | |
118002247 | panitumumab | Palmar-plantar erythrodysaesthesia syndrome | AMGEN | 79.00 YR | F | 32 KG | 20160910 | JP |
122329126 | panitumumab | Palmar-plantar erythrodysaesthesia syndrome | AMGEN | 59.00 YR | M | 66 KG | 20160811 | JP |
124317734 | panitumumab | Palmar-plantar erythrodysaesthesia syndrome | AMGEN | 67.00 YR | F | 55 KG | 20160803 | JP |
124904633 | panitumumab | Palmar-plantar erythrodysaesthesia syndrome | AMGEN | 0.00 | F | 55 KG | 20160711 | JP |
126918812 | panitumumab | Palmar-plantar erythrodysaesthesia syndrome | AMGEN | 65.00 YR | M | 69 KG | 20160906 | JP |
127567761 | panitumumab | Palmar-plantar erythrodysaesthesia syndrome | AMGEN | 66.00 YR | M | 61 KG | 20160917 | JP |
Total Records: 7 Number of Pages: 1